Fiera Capital Corp Purchases New Stake in Balchem Co. (NASDAQ:BCPC)

Fiera Capital Corp acquired a new position in shares of Balchem Co. (NASDAQ:BCPC) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 23,869 shares of the basic materials company’s stock, valued at approximately $4,201,000. Fiera Capital Corp owned about 0.07% of Balchem at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in BCPC. Vanguard Group Inc. boosted its position in shares of Balchem by 3.8% during the first quarter. Vanguard Group Inc. now owns 3,935,935 shares of the basic materials company’s stock valued at $609,873,000 after buying an additional 144,423 shares during the last quarter. Conestoga Capital Advisors LLC lifted its stake in Balchem by 1.8% during the 3rd quarter. Conestoga Capital Advisors LLC now owns 1,175,569 shares of the basic materials company’s stock valued at $206,900,000 after acquiring an additional 20,360 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in Balchem by 0.9% during the 2nd quarter. Dimensional Fund Advisors LP now owns 697,461 shares of the basic materials company’s stock worth $107,372,000 after acquiring an additional 5,977 shares during the last quarter. Congress Asset Management Co. grew its stake in shares of Balchem by 12.4% in the 3rd quarter. Congress Asset Management Co. now owns 301,440 shares of the basic materials company’s stock worth $53,053,000 after acquiring an additional 33,373 shares in the last quarter. Finally, Bank of New York Mellon Corp raised its holdings in shares of Balchem by 1.2% in the second quarter. Bank of New York Mellon Corp now owns 277,475 shares of the basic materials company’s stock valued at $42,717,000 after purchasing an additional 3,279 shares during the last quarter. 87.91% of the stock is owned by institutional investors.

Analyst Ratings Changes

BCPC has been the subject of a number of recent analyst reports. StockNews.com raised shares of Balchem from a “hold” rating to a “buy” rating in a research report on Monday, October 28th. HC Wainwright upped their target price on Balchem from $185.00 to $190.00 and gave the company a “buy” rating in a report on Monday, November 4th.

Balchem Price Performance

Shares of NASDAQ:BCPC opened at $179.32 on Friday. The company has a market capitalization of $5.83 billion, a P/E ratio of 48.20, a price-to-earnings-growth ratio of 5.48 and a beta of 0.65. The company’s 50-day moving average is $172.12 and its 200 day moving average is $164.24. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.90 and a current ratio of 2.98. Balchem Co. has a fifty-two week low of $116.84 and a fifty-two week high of $186.03.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.